Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.19.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Feb. 28, 2019
Aug. 31, 2018
Current    
Cash and cash equivalents $ 3,093,211 $ 1,727,184
Marketable Securities (Note 19) 71,127 10,151
Accounts and other receivables (Note 6) 219,105 265,751
Inventory (Note 7) 108,018 87,233
Prepaid expenses (Note 18) 149,103 193,732
Total Current Assets 3,640,564 2,284,051
Patents (Note 8) 200,186 146,538
Property & Equipment (Note 9) 432,793 1,237
Property & Equipment Gross 632,979 147,775
TOTAL ASSETS 4,273,543 2,431,826
Current    
Accounts payable and accrued liabilities (Note 10) 494,458 35,785
Due to related parties (Note 15) 5,621 7,855
Total Current Liabilities 500,079 43,640
TOTAL LIABILITIES 500,079 43,640
STOCKHOLDERS' EQUITY    
Share Capital Authorized: 220,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 78,002,086 common shares at February 28, 2019 and 75,533,471 common shares at August 31, 2018 78,002 75,533
Additional paid-in capital 24,318,746 22,095,682
Accumulated other comprehensive loss (14,247)
Deficit (21,618,149) (19,768,782)
Equity attributable to shareholders 2,778,599 2,388,186
Non-controlling Interest 994,865
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 4,273,543 $ 2,431,826